Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Spdr S&p Biotech EtfETF ST STR SP BIOT | 484,000 | 431,215 | -52,785 | $43.22M | $40.92M | 9.31% | -$2.30M |
| Stereotaxis, Inc.(STXS) | 13,680,554 | 13,680,554 | 0 | $23.94M | $35.71M | 8.13% | +$11.77M |
| Cytokinetics, Incorporated(CYTK) | 400,000 | 398,100 | -1,900 | $33.40M | $27.91M | 6.35% | -$5.49M |
| IDEAYA Biosciences, Inc.(IDYA) | 516,341 | 446,341 | -70,000 | $18.37M | $19.59M | 4.46% | +$1.21M |
| Merus N V | 454,870 | 378,995 | -75,875 | $12.51M | $17.07M | 3.89% | +$4.56M |
| Revolution Medicines, Inc.(RVMD) | 511,894 | 511,894 | 0 | $14.68M | $16.50M | 3.76% | +$1.82M |
| Viking Therapeutics, Inc.(VKTX) | 248,217 | 194,117 | -54,100 | $4.62M | $15.92M | 3.62% | +$11.30M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 742,574 | 659,574 | -83,000 | $16.05M | $15.70M | 3.57% | -$349.2K |
| Ishares Nasdaq Biotech IndxETF | 102,500 | 102,500 | 0 | $13.92M | $14.07M | 3.20% | +$140.4K |
| Ascendis Pharma A/SADR(ASND) | 123,472 | 92,472 | -31,000 | $15.55M | $13.98M | 3.18% | -$1.57M |
| Xenon Pharmaceuticals Inc.(XENE) | 276,739 | 273,739 | -3,000 | $12.75M | $11.78M | 2.68% | -$962.1K |
| Day One Biopharmaceuticals I COM | 686,463 | 666,463 | -20,000 | $10.02M | $11.01M | 2.51% | +$987.6K |
| Blueprint Medicines Corp | 110,863 | 106,763 | -4,100 | $10.23M | $10.13M | 2.31% | -$98.5K |
| Neurocrine Biosciences, Inc.(NBIX) | 72,615 | 71,615 | -1,000 | $9.57M | $9.88M | 2.25% | +$309.4K |
| Kalvista Pharmaceuticals Inc | 601,032 | 806,973 | +205,941 | $7.36M | $9.57M | 2.18% | +$2.21M |
| Tandem Diabetes Care, Inc.(TNDM) | 220,708 | 258,208 | +37,500 | $6.53M | $9.14M | 2.08% | +$2.61M |
| DexCom, Inc.(DXCM) | 67,552 | 65,552 | -2,000 | $8.38M | $9.09M | 2.07% | +$709.5K |
| Kura Oncology, Inc.(KURA) | 492,684 | 412,663 | -80,021 | $7.08M | $8.80M | 2.00% | +$1.72M |
| AtriCure, Inc.(ATRC) | 125,529 | 271,029 | +145,500 | $4.48M | $8.24M | 1.88% | +$3.76M |
| Morphic Holding Inc | 231,748 | 231,748 | 0 | $6.69M | $8.16M | 1.86% | +$1.46M |
| Axogen, Inc.(AXGN) | 935,894 | 935,894 | 0 | $6.39M | $7.55M | 1.72% | +$1.16M |
| Biohaven Ltd.(BHVN) | 168,772 | 118,730 | -50,042 | $7.22M | $6.49M | 1.48% | -$730.1K |
| 2seventy Bio Inc | 1,447,465 | 1,204,051 | -243,414 | $6.18M | $6.44M | 1.47% | +$261.0K |
| Edgewise Therapeutics, Inc.(EWTX) | 449,384 | 306,197 | -143,187 | $4.92M | $5.59M | 1.27% | +$668.8K |
| Alector Inc | 609,905 | 912,928 | +303,023 | $4.87M | $5.50M | 1.25% | +$628.8K |
| Century Therapeutics, Inc.(IPSC) | 1,307,407 | 1,307,407 | 0 | $4.34M | $5.46M | 1.24% | +$1.12M |
| Larimar Therapeutics, Inc.(LRMR) | 323,873 | 656,373 | +332,500 | $1.47M | $4.98M | 1.13% | +$3.51M |
| Ascendis Pharma A/SNOTE 2 250 4 0(ASND) | 0 | 0 | 0 | $4.14M | $4.61M | 1.05% | +$471.3K |
| Keros Therapeutics, Inc.(KROS) | 74,361 | 67,754 | -6,607 | $2.96M | $4.49M | 1.02% | +$1.53M |
| Arcus Biosciences, Inc.(RCUS) | 232,717 | 231,717 | -1,000 | $4.44M | $4.37M | 1.00% | -$70.1K |
| Lakefront Biotherapeutics NVADR(LKFT) | 130,175 | 130,175 | 0 | $5.29M | $4.19M | 0.95% | -$1.10M |
| Perspective Therapeutics, Inc.(CATX) | 0 | 3,103,644 | +3,103,644 | $0 | $3.69M | 0.84% | +$3.69M |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 709,500 | 709,500 | 0 | $4.25M | $3.60M | 0.82% | -$645.6K |
| Astria Therapeutics Inc | 449,008 | 223,265 | -225,743 | $3.45M | $3.14M | 0.72% | -$305.9K |
| Regulus Therapeutics Inc | 1,111,049 | 1,070,548 | -40,501 | $1.42M | $3.08M | 0.70% | +$1.66M |
| Bicycle Therapeutics PlcADS | 122,200 | 122,200 | 0 | $2.21M | $3.04M | 0.69% | +$833.4K |
| Accuray Inc | 1,222,358 | 1,222,358 | 0 | $3.46M | $3.02M | 0.69% | -$440.0K |
| Insulet Corporation(PODD) | 0 | 15,900 | +15,900 | $0 | $2.73M | 0.62% | +$2.73M |
| PROCEPT BioRobotics Corporation(PRCT) | 63,300 | 54,995 | -8,305 | $2.65M | $2.72M | 0.62% | +$65.0K |
| MediWound Ltd.SHS NEW(MDWD) | 257,653 | 188,753 | -68,900 | $2.62M | $2.69M | 0.61% | +$69.4K |
| ARS Pharmaceuticals, Inc.(SPRY) | 311,169 | 239,194 | -71,975 | $1.71M | $2.44M | 0.56% | +$739.4K |
| Aquestive Therapeutics Inc | 0 | 500,000 | +500,000 | $0 | $2.13M | 0.48% | +$2.13M |
| Proqr Therapeutics N VSHS EURO SHS EURO | 940,582 | 905,582 | -35,000 | $1.86M | $2.07M | 0.47% | +$211.3K |
| COMPASS Pathways plcADS(CMPS) | 193,000 | 243,210 | +50,210 | $1.69M | $2.02M | 0.46% | +$334.8K |
| Lineage Cell Therapeutics, Inc.(LCTX) | 0 | 1,366,308 | +1,366,308 | $0 | $2.02M | 0.46% | +$2.02M |
| Stoke Therapeutics, Inc.(STOK) | 0 | 145,000 | +145,000 | $0 | $1.96M | 0.45% | +$1.96M |
| Sutro Biopharma, Inc.(STRO) | 283,079 | 334,079 | +51,000 | $1.21M | $1.89M | 0.43% | +$673.1K |
| Inogen, Inc.(INGN) | 15,000 | 208,790 | +193,790 | $82.3K | $1.68M | 0.38% | +$1.60M |
| Gossamer Bio, Inc.(GOSS) | 1,476,052 | 1,409,262 | -66,790 | $1.35M | $1.66M | 0.38% | +$316.0K |
| BrainsWay Ltd.ADS(BWAY) | 308,471 | 297,655 | -10,816 | $2.00M | $1.57M | 0.36% | -$424.3K |
| BioNTech SEADS(BNTX) | 0 | 17,000 | +17,000 | $0 | $1.57M | 0.36% | +$1.57M |
| Immatics N.V.SHS(IMTX) | 105,000 | 145,000 | +40,000 | $1.11M | $1.52M | 0.35% | +$418.3K |
| Neuronetics, Inc.(STIM) | 313,717 | 313,717 | 0 | $909.8K | $1.49M | 0.34% | +$583.5K |
| Adicet Bio Inc | 0 | 600,000 | +600,000 | $0 | $1.41M | 0.32% | +$1.41M |
| Autolus Therapeutics plcADS(AUTL) | 191,070 | 216,667 | +25,597 | $1.23M | $1.38M | 0.31% | +$151.8K |
| Acelyrin Inc | 371,200 | 202,587 | -168,613 | $2.77M | $1.37M | 0.31% | -$1.40M |
| Iteos Therapeutics Inc | 98,560 | 98,560 | 0 | $1.08M | $1.34M | 0.31% | +$265.1K |
| Mineralys Therapeutics, Inc.(MLYS) | 15,200 | 90,000 | +74,800 | $130.7K | $1.16M | 0.26% | +$1.03M |
| Compugen Ltd.(CGEN) | 205,202 | 430,202 | +225,000 | $406.3K | $1.11M | 0.25% | +$703.6K |
| Immunovant, Inc.(IMVT) | 40,742 | 29,416 | -11,326 | $1.72M | $950.4K | 0.22% | -$766.0K |
| Acrivon Therapeutics Inc | 131,351 | 131,351 | 0 | $646.2K | $939.2K | 0.21% | +$292.9K |
| Aprea Therapeutics, Inc.(APRE) | 0 | 137,174 | +137,174 | $0 | $917.7K | 0.21% | +$917.7K |
| PolyPid Ltd.(PYPD) | 0 | 185,446 | +185,446 | $0 | $853.1K | 0.19% | +$853.1K |
| Syros Pharmaceuticals Inc | 214,885 | 135,850 | -79,035 | $1.67M | $726.8K | 0.17% | -$947.2K |
| Adaptimmune Therapeutics plcADR(ADAPY) | 351,064 | 341,064 | -10,000 | $278.4K | $538.9K | 0.12% | +$260.5K |
| Masimo Corp | 3,000 | 3,000 | 0 | $351.6K | $440.6K | 0.10% | +$88.9K |
| Nevro Corp | 28,000 | 28,000 | 0 | $602.6K | $404.3K | 0.09% | -$198.2K |
| Karyopharm Therapeutics Inc.(KPTI) | 192,678 | 192,678 | 0 | $166.7K | $290.9K | 0.07% | +$124.3K |
| Vigil Neuroscience Inc | 71,815 | 71,815 | 0 | $242.7K | $244.9K | 0.06% | +$2.2K |
| Compass Therapeutics, Inc.(CMPX) | 116,882 | 116,882 | 0 | $182.3K | $231.4K | 0.05% | +$49.1K |
| Spero Therapeutics, Inc.(SPRO) | 125,000 | 125,000 | 0 | $183.8K | $215.0K | 0.05% | +$31.3K |
| Alto Neuroscience, Inc.(ANRO) | 0 | 10,000 | +10,000 | $0 | $153.5K | 0.03% | +$153.5K |
| Amylyx Pharmaceuticals, Inc.(AMLX) | 122,547 | 0 | -122,547 | $1.80M | $0 | — | -$1.80M |
| argenx SEADR(ARGX) | 3,600 | 0 | -3,600 | $1.37M | $0 | — | -$1.37M |
| Cullinan Therapeutics, Inc.(CGEM) | 127,284 | 0 | -127,284 | $1.30M | $0 | — | -$1.30M |
| Elevation Oncology Inc | 450,000 | 0 | -450,000 | $241.7K | $0 | — | -$241.7K |
| Immunogen Inc | 193,661 | 0 | -193,661 | $5.74M | $0 | — | -$5.74M |
| Karuna Therapeutics Inc | 48,145 | 0 | -48,145 | $15.24M | $0 | — | -$15.24M |
| Kinnate Biopharma Inc | 50,000 | 0 | -50,000 | $118.5K | $0 | — | -$118.5K |
| MacroGenics, Inc.(MGNX) | 152,250 | 0 | -152,250 | $1.46M | $0 | — | -$1.46M |
| Mereo BioPharma Group plcADS(MREO) | 778,813 | 0 | -778,813 | $1.80M | $0 | — | -$1.80M |
| Mirati Therapeutics Inc | 89,387 | 0 | -89,387 | $5.25M | $0 | — | -$5.25M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 72,797 | 0 | -72,797 | $669.7K | $0 | — | -$669.7K |
| Sage Therapeutics Inc | 245,000 | 0 | -245,000 | $5.31M | $0 | — | -$5.31M |
| Spruce Biosciences Inc | 548,510 | 0 | -548,510 | $1.61M | $0 | — | -$1.61M |
| Vistagen Therapeutics, Inc.(VTGN) | 41,886 | 0 | -41,886 | $215.3K | $0 | — | -$215.3K |